NRD
Nebula Research & Development Portfolio holdings
AUM
$1.17B
1-Year Return
15.19%
This Quarter Return
+4.65%
1 Year Return
+15.19%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$464M
AUM Growth
+$133M
(+40%)
Cap. Flow
+$126M
Cap. Flow
% of AUM
27.21%
Top 10 Holdings %
Top 10 Hldgs %
4.65%
Holding
1,048
New
429
Increased
140
Reduced
134
Closed
345
Top Buys
| 1 |
PVH
PVH
|
$2.16M |
| 2 |
Twilio
TWLO
|
$2.16M |
| 3 |
UnitedHealth
UNH
|
$2.16M |
| 4 |
Micron Technology
MU
|
$2.16M |
| 5 |
Warner Music
WMG
|
$2.15M |
Top Sells
| 1 |
AppFolio
APPF
|
$1.79M |
| 2 |
Cheniere Energy
LNG
|
$1.61M |
| 3 |
Republic Services
RSG
|
$1.61M |
| 4 |
Bank of America
BAC
|
$1.6M |
| 5 |
Gartner
IT
|
$1.6M |
Sector Composition
| 1 | Industrials | 16.97% |
| 2 | Technology | 15.63% |
| 3 | Consumer Discretionary | 13.68% |
| 4 | Healthcare | 13.09% |
| 5 | Financials | 9.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
376
Hexcel
HXL
$5.16B
| $465K | 0.1% |
+6,380
| New | +$465K |
|
377
Genuine Parts
GPC
$19.4B
| $464K | 0.1% |
2,992
-560
| -16% | -$86.8K |
|
378
Ferrari
RACE
$87.1B
| $463K | 0.1% |
1,061
-638
| -38% | -$278K |
|
379
PayPal
PYPL
$65.2B
| $462K | 0.1% |
+6,894
| New | +$462K |
|
380
Red Rock Resorts
RRR
$3.7B
| $462K | 0.1% |
+7,718
| New | +$462K |
|
381
Douglas Emmett
DEI
$2.83B
| $461K | 0.1% |
+33,264
| New | +$461K |
|
382
Ligand Pharmaceuticals
LGND
$3.25B
| $461K | 0.1% |
+6,300
| New | +$461K |
|
|
MZTI
383
The Marzetti Company Common Stock
MZTI
$5.08B
| $460K | 0.1% |
+2,216
| New | +$460K |
|
384
Scholar Rock
SRRK
$3.02B
| $459K | 0.1% |
+25,841
| New | +$459K |
|
385
Gogo Inc
GOGO
$1.43B
| $458K | 0.1% |
+52,185
| New | +$458K |
|
386
Hamilton Lane
HLNE
$6.36B
| $455K | 0.1% |
+4,035
| New | +$455K |
|
387
FirstService
FSV
$9.18B
| $455K | 0.1% |
+2,743
| New | +$455K |
|
388
Interpublic Group of Companies
IPG
$9.94B
| $454K | 0.1% |
+13,924
| New | +$454K |
|
389
Alta Equipment Group
ALTG
$275M
| $454K | 0.1% |
35,051
-4,643
| -12% | -$60.1K |
|
390
Teekay
TK
$718M
| $452K | 0.1% |
62,049
-9,573
| -13% | -$69.7K |
|
391
Regeneron Pharmaceuticals
REGN
$60.8B
| $451K | 0.1% |
469
-1,079
| -70% | -$1.04M |
|
392
Texas Roadhouse
TXRH
$11.2B
| $449K | 0.1% |
+2,908
| New | +$449K |
|
393
Core Laboratories
CLB
$592M
| $449K | 0.1% |
+26,282
| New | +$449K |
|
394
LeMaitre Vascular
LMAT
$2.21B
| $449K | 0.1% |
6,764
+492
| +8% | +$32.6K |
|
395
REV Group
REVG
$3.05B
| $449K | 0.1% |
20,315
+7,973
| +65% | +$176K |
|
396
Oil States International
OIS
$334M
| $447K | 0.1% |
+72,601
| New | +$447K |
|
397
BioMarin Pharmaceuticals
BMRN
$11.1B
| $447K | 0.1% |
+5,114
| New | +$447K |
|
398
Zoetis
ZTS
$67.9B
| $444K | 0.1% |
+2,626
| New | +$444K |
|
399
Essent Group
ESNT
$6.29B
| $443K | 0.1% |
+7,452
| New | +$443K |
|
400
Sapiens International
SPNS
$2.4B
| $441K | 0.1% |
13,722
+753
| +6% | +$24.2K |
|